Qiagen Officials Talk TB Test, GeneReader Opportunities at Piper Jaffray Conference | GenomeWeb

NEW YORK (GenomeWeb Daily News) — Speaking at Piper Jaffray's annual healthcare conference today, members of Qiagen's management team provided investors with a recap of recent business activities and a glimpse of what's to come.

Qiagen CFO Roland Sackers told investors that the firm saw "very nice underlying growth" from its molecular diagnostics and applied testing businesses in 2013, with "stabilization" in its pharmaceutical/life sciences research products business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.